Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children
Background. Methotrexate (MTX), used in high doses (1000–5000 mg / m2), has proven to be one of the key components of successful therapy for non‑Hodgkin’s lymphomas. However, the flip side of high efficacy is its toxicity. Even adherence to modern guidelines for supportive care, including therapeuti...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2025-03-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/1002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|